BNP/CALL/MERCK & CO./150/0.1/17.01.25 Share Price

Warrant

DE000PC5FHG8

Market Closed - Boerse Frankfurt Warrants 01:20:41 29/06/2024 am IST
0.14 EUR -30.00% Intraday chart for BNP/CALL/MERCK & CO./150/0.1/17.01.25
1 month-12.50%
3 months-62.16%
Date Price Change
28/24/28 0.14 -30.00%
27/24/27 0.2 -16.67%
26/24/26 0.24 -7.69%
25/24/25 0.26 -.--%
24/24/24 0.26 +30.00%

Real-time Boerse Frankfurt Warrants

Last update June 29, 2024 at 01:20 am IST

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying MERCK & CO., INC.
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PC5FHG
ISINDE000PC5FHG8
Date issued 21/02/2024
Strike 150 $
Maturity 17/01/2025 (201 Days)
Parity 10 : 1
Emission price 0.23
Emission volume N/A
Settlement Barausgleich
Currency EUR

Technical Indicators

Highest since issue 0.41
Lowest since issue 0.14
Spread 0.01
Spread %8.33%

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
123.8 USD
Average target price
142.7 USD
Spread / Average Target
+15.25%
Consensus